| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/18/2013 | EP2131860B1 Anti-sclerostin antibodies |
| 12/18/2013 | EP2057193B1 Ephb3-specific antibody and uses thereof |
| 12/18/2013 | EP1974023B1 Dengue chimeric viruses |
| 12/18/2013 | EP1656952B1 Polyalkylene glycol conjugates of interferon beta-1A and uses thereof |
| 12/18/2013 | EP1648427B1 Low dose IgM antibody treatment of demyelinating disorders |
| 12/18/2013 | EP1523991B1 Anti-cancer vaccine |
| 12/18/2013 | EP0647275B2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 12/18/2013 | CN103459608A Recombinant polypeptide production method |
| 12/18/2013 | CN103459595A Antibody against human prostaglandin E2 receptor EP4 |
| 12/18/2013 | CN103459425A Means and methods for treating DLBCL |
| 12/18/2013 | CN103459414A Protein having antigen activity against liver flukes |
| 12/18/2013 | CN103459410A Rapid selection method for HIV gp-120 variants |
| 12/18/2013 | CN103458927A Treatment of fistulizing crohn's disease |
| 12/18/2013 | CN103458926A Improved high concentration anti-TNF-alpha antibody liquid formulations |
| 12/18/2013 | CN103458925A Process for producing an immunogenic composition containing tetanus toxoid |
| 12/18/2013 | CN103458924A Adjuvant compositions with 4-lBBL |
| 12/18/2013 | CN103458923A Method for the production of protein complexes and vaccine compositions comprising the same |
| 12/18/2013 | CN103458922A Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses |
| 12/18/2013 | CN103451199A HIV-1 (human immunodeficiency virus-1) multi-epitope DNA (deoxyribonucleic acid) vaccine |
| 12/18/2013 | CN103451196A Codon optimized porcine circovirus type 2 Cap protein coding gene and application thereof |
| 12/18/2013 | CN103451195A Mutant phage lysis gene E, lysis plasmid vector containing lysis gene and application in preparation of bacterial ghost vaccines |
| 12/18/2013 | CN103451158A Materials and methods for respiratory disease control in canines |
| 12/18/2013 | CN103450360A Antibodies to cd40 |
| 12/18/2013 | CN103450359A Antagonist antibodies against GDF-8 and uses in treatment ofals and other GDF-8-associated disorders |
| 12/18/2013 | CN103450353A Application of protein AIG_01780 in Rickettsia rickettsii resistant immune protection |
| 12/18/2013 | CN103450347A Polypeptide and gene vaccine used for treating alzheimer disease |
| 12/18/2013 | CN103446585A Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid and lung cancer and therapeutic use of ProNGF |
| 12/18/2013 | CN103446584A Method of treating hemolytic disease |
| 12/18/2013 | CN103446583A Human antibody preparation for treating TNF (tumour necrosis factor)-alpha related diseases |
| 12/18/2013 | CN103446582A Novel vaccine containing adjuvant capable of inducing mucosal immunity |
| 12/18/2013 | CN103446581A Method for preparing bacterial ghost vaccine of haemophilus parasuis as well as product and application thereof |
| 12/18/2013 | CN103446580A Tumor vaccine and preparation method thereof |
| 12/18/2013 | CN103446182A Preparation method of specific transfer factor for highly pathogemc pathogenic porcine reproductive and respiratory syndrome |
| 12/18/2013 | CN102747045B Swine influenza virus H1N1 SIVTJ inactivated vaccine and preparation method thereof |
| 12/18/2013 | CN102732510B Method for simultaneously removing bacillus anthracis virulence megaplasmids pXO1 and pXO2 |
| 12/18/2013 | CN102526718B Recombinant H5N1 (Hemagglutinin 5 Neuraminidase 1) avian influenza virus cell vaccine and application thereof |
| 12/18/2013 | CN102276730B Preparation method for staphylococcus aureus Iron-regulated surface determinant B immunodominant fragment (IsdBid)-target of RNAIII activating protein (TRAP) fusion protein and application thereof |
| 12/18/2013 | CN102228698B HPV58 (Human Papilloma Virus) type therapeutic composite genetic vaccine and construction method thereof |
| 12/18/2013 | CN102205117B Dairy cow mammitis staphylococcus aureus-Escherichia coli bigeminy polyvalent vaccine and preparation method thereof |
| 12/18/2013 | CN102140441B Bird flu vaccine by using attenuated vaccinia Tian Tan as vector |
| 12/18/2013 | CN101910200B Improved NOGO-A binding molecules and pharmaceutical use thereof |
| 12/18/2013 | CN101801407B Inhibitors of receptor tyrosine kinases and methods of use thereof |
| 12/18/2013 | CN101704870B Glutaryl cholesterol and liposome thereof and application of liposome as vaccine adjuvant |
| 12/18/2013 | CN101333244B Protein purification by ion exchange chromatography |
| 12/18/2013 | CN101124240B Specific binding agents to hepatocyte growth factor |
| 12/17/2013 | US8609822 Neutralizing antibodies and methods of use thereof |
| 12/17/2013 | US8609817 Anti-hepcidin-25 selective antibodies and uses thereof |
| 12/17/2013 | US8609624 Methods and compositions for the inhibition of Stat5 in prostate cancer cells |
| 12/17/2013 | US8609605 Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4+ T cell response to APOB100 |
| 12/17/2013 | US8609395 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 12/17/2013 | US8609114 Methods of using a vaccine composition containing synthetic adjuvant |
| 12/17/2013 | US8609113 Botulinum toxin treatments of depression |
| 12/17/2013 | US8609112 Botulinum toxin treatments of depression |
| 12/17/2013 | US8609111 Antibodies against clostridium difficile toxins and uses thereof |
| 12/17/2013 | US8609110 Citrobacter freundii antibacterial agents and their use |
| 12/17/2013 | US8609109 HIV vaccine formulations |
| 12/17/2013 | US8609108 Gamma-glutamyl transpeptidase attenuated Francisella |
| 12/17/2013 | US8609107 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 12/17/2013 | US8609106 Combinations of pneumococcal RrgB clades |
| 12/17/2013 | US8609105 Auristatin drug linker conjugates |
| 12/17/2013 | US8609104 Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates |
| 12/17/2013 | US8609103 Megalin-based delivery of therapeutic compounds to the brain and other tissues |
| 12/17/2013 | US8609102 Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of ISAA or ISAB |
| 12/17/2013 | US8609101 Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies |
| 12/17/2013 | US8609100 Method for inhibiting dendritic cell immunoreceptor (DCIR)-mediated human immunodeficiency virus infection comprising administering anti-DCIR antibodies |
| 12/17/2013 | US8609099 Antibodies that bind both IL-17A and IL-17F |
| 12/17/2013 | US8609098 Composition for repression of hyperlipidemia and obesity through suppression of intestinal cholesterol absorption |
| 12/17/2013 | US8609097 Use of an anti-Tau pS422 antibody for the treatment of brain diseases |
| 12/17/2013 | US8609095 Anti-HER2 antibodies and compositions |
| 12/17/2013 | US8609094 Endoglin antibodies |
| 12/17/2013 | US8609093 Methods of treatment using anti-IL-17F antibodies |
| 12/17/2013 | US8609092 Antibody drug conjugates (ADC) that bind to 161P2F10B proteins |
| 12/17/2013 | US8609091 Method for endocytic presentation of an immunosuppressive for the treatment of type 1 diabetes |
| 12/17/2013 | US8609090 Specific binding agents to hepatocyte growth factor |
| 12/17/2013 | US8609089 Compositions of PD-1 antagonists and methods of use |
| 12/17/2013 | DE212011100195U1 Antikörper, der das Tumorwachstum stoppt oder verzögert (Varianten) Antibody will stop tumor growth and delayed (variants) |
| 12/17/2013 | CA2748520C Pharmaceutical composition containing an anionic drug, and a production method therefor |
| 12/17/2013 | CA2659774C Use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 12/17/2013 | CA2617051C Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 12/17/2013 | CA2564769C Cellular permissivity factor for viruses, and uses thereof |
| 12/17/2013 | CA2563538C Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
| 12/17/2013 | CA2555413C An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof |
| 12/17/2013 | CA2536254C Recombinant double-stranded rna phages and uses thereof |
| 12/17/2013 | CA2508228C Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 12/17/2013 | CA2492598C Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 12/17/2013 | CA2478855C Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 12/17/2013 | CA2459510C Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods |
| 12/17/2013 | CA2438698C Immunogen adherence inhibitor and method of making and using same |
| 12/17/2013 | CA2427310C Imaging, diagnosis and treatment of angiogenesis-related diseases comprising ecsm4 |
| 12/17/2013 | CA2410883C Methods for isolating and using fungal hemolysins |
| 12/17/2013 | CA2395423C P. gingivalis antigenic composition |
| 12/17/2013 | CA2370563C Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 12/13/2013 | CA2816009A1 Anti-trka antibodies, derivatives and uses thereof |
| 12/12/2013 | WO2013185130A2 Microbes with controlled adhesive properties |
| 12/12/2013 | WO2013185032A1 Nanotherapeutics for drug targeting |
| 12/12/2013 | WO2013185010A1 HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES |
| 12/12/2013 | WO2013184976A2 Compositions and methods for antigen-specific tolerance |
| 12/12/2013 | WO2013184912A2 Binding agents that modulate the hippo pathway and uses thereof |
| 12/12/2013 | WO2013184900A2 Immunogenic compositions and related methods |
| 12/12/2013 | WO2013184200A1 Human monoclonal antibodies against human chemokine receptor ccr7 |